Wake Forest University Health Sciences
Clinical trials sponsored by Wake Forest University Health Sciences, explained in plain language.
-
Hernia mesh showdown: fortiva vs strattice – but study stalls
Disease control TerminatedThis study compared two biologic meshes, Fortiva and Strattice, used to repair ventral hernias. The goal was to see which mesh led to fewer hernias coming back and fewer complications. Only 6 people took part before the study was stopped early, so the results are very limited.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
New combo therapy for aggressive sarcoma shows early safety data
Disease control TerminatedThis early-phase study tested the safety and best dose of two chemotherapy drugs (gemcitabine and docetaxel) given together with radiation before surgery for adults with large, high-grade soft tissue sarcoma in the arms or legs. Only 9 people took part before the study was stoppe…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 26, 2026 02:54 UTC
-
Liver cancer combo therapy study halted after just 2 patients
Disease control TerminatedThis study tested whether adding electromagnetic fields to the drug regorafenib could help people with advanced liver cancer live longer without their cancer growing. It was designed for patients who had already tried other treatments. However, the study was stopped early after o…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Spinal cancer combo therapy study ends early after just one patient
Disease control TerminatedThis early-stage study tested whether combining precise radiation to the spine with the immunotherapy drug pembrolizumab is feasible for people with advanced spinal tumors pressing on the spinal cord. Only one person enrolled before the study was stopped early. The goal was to se…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Virtual group helps young cancer survivors cope during COVID
Symptom relief TerminatedThis study tested an online support group for young adults (ages 18-39) who had cancer treatment and were feeling anxious or distressed during the pandemic. The goal was to see if teaching healthy coping skills through video sessions could improve their mood and confidence. The s…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 26, 2026 03:00 UTC
-
Tiny study tests blood flow trick for shoulder recovery
Symptom relief TerminatedThis study looked at whether blood flow restriction therapy could help people regain shoulder muscle strength and size after an injury. Only 3 people took part before the study was stopped early. Researchers measured strength, pain, and function using special machines and questio…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
New wound-closing method may help high-risk surgery patients heal better
Symptom relief TerminatedThis study looked at a different way to close surgical cuts in the belly for women at high risk of wound problems after gynecologic surgery. Instead of leaving the wound open to heal, doctors partially closed it right after surgery and fully closed it 4-7 days later. The goal was…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
Spinal zap device tested for diabetic foot pain
Symptom relief TerminatedThis small study tested a spinal cord stimulator (BurstDR SCS) to treat painful diabetic neuropathy in 6 adults whose pain did not respond to standard medications. The goal was to see if the device could reduce leg pain by at least half. The study was terminated early, so results…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC
-
Wakefulness drug studied for brain tumor fatigue
Symptom relief TerminatedThis study tested a drug called solriamfetol to see if it could help people with brain tumors (gliomas) feel more awake and improve their memory, mood, and quality of life. Only 2 people enrolled before the study was stopped early. The main goal was to check for side effects.
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 18, 2026 12:08 UTC
-
Tiny nerve zapper eases knee pain without surgery?
Symptom relief TerminatedThis study tested a temporary device that stimulates nerves around the knee to relieve chronic pain from osteoarthritis. Twelve adults with knee pain received the treatment, and researchers measured changes in pain intensity and quality of life. The goal was to see if this non-su…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC
-
Heart pump study aims to prevent brain damage by measuring blood flow
Knowledge-focused TerminatedThis study looked at how blood flows to the brain in people using mechanical heart pumps (like LVADs or ECMO). The goal was to find normal brain blood flow values for each pump type, so doctors can adjust pump settings to avoid brain injury. Only 6 adults were enrolled before the…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 02:59 UTC
-
Antifungal drug studied for brain tumor treatment
Knowledge-focused TerminatedThis early-stage study looked at whether ketoconazole, an antifungal drug, could block a protein called tGLI1 in brain tumors. The study included 15 people with either breast cancer that spread to the brain or a type of brain tumor called glioma. The goal was to see if the drug c…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 02:46 UTC
-
Lung cancer survivor Follow-Up study ends early
Knowledge-focused TerminatedThis pilot study tested a program called SHAREDCare, which helps lung cancer survivors and a navigator work together to address their needs after treatment. The goal was to improve follow-up care by creating a shared plan that considers each person's situation and goals. Only 5 p…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 02:45 UTC
-
Can a simple patch improve diabetes care before surgery?
Knowledge-focused TerminatedThis pilot study tested whether continuous glucose monitors (CGMs) could be used in preoperative clinics to help manage blood sugar in people with diabetes before surgery. Researchers placed CGMs on 22 adults during their preoperative visit and tracked accuracy compared to standa…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC
-
Can the 'Love Hormone' ease arthritis pain? small study investigates
Knowledge-focused TerminatedThis study looked at whether oxytocin, a natural hormone, can reduce pain when given through an IV. It included 7 people—some healthy and some with severe knee arthritis. Researchers measured pain from a heated skin patch to see how oxytocin changes pain perception.
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC